<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND STUDY AIMS: The aim of this retrospective study was to assess safety and efficacy of stepwise radical endoscopic resection (SRER) in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with high-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> (HGIN) or early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: Patients undergoing SRER between 2000 and 2006 were retrospectively evaluated </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> who also had HGIN or early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were included if they had no signs of submucosal infiltration or <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>SRER was performed using the cap-technique, at 8-week intervals until <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> was removed </plain></SENT>
<SENT sid="4" pm="."><plain>Follow-up endoscopy was scheduled every 6 months </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A total of 34 patients were included (31 male, mean 67 years, median Barrett's dimensions C1M4) </plain></SENT>
<SENT sid="6" pm="."><plain>HGIN / early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was eradicated in <z:hpo ids='HP_0000001'>all</z:hpo> patients in a median of two endoscopic resection sessions (IQR 1-2 sessions) </plain></SENT>
<SENT sid="7" pm="."><plain>Twelve patients underwent additional <z:chebi fb="17" ids="49474,49475">argon</z:chebi> plasma coagulation for small islets or an irregular Z-line </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> was eradicated in 28 patients (82 %) </plain></SENT>
<SENT sid="9" pm="."><plain>Complications occurred in 3/34 patients (9 %): two <z:mpath ids='MPATH_81'>perforations</z:mpath>, one delayed <z:mp ids='MP_0001914'>bleeding</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo>, 19 patients (56 %) developed <z:hpo ids='HP_0002015'>dysphagia</z:hpo>, which was resolved with <z:mpath ids='MPATH_66'>dilatation</z:mpath> or stent placement </plain></SENT>
<SENT sid="11" pm="."><plain>During a median follow-up period of 23 months (IQR 15 - 41 months), HGIN / early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> recurred in three patients (9 %): two were retreated with endoscopic resection and one patient was referred for curative surgery </plain></SENT>
<SENT sid="12" pm="."><plain>Five patients (15 %) had recurrence of nondysplastic <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>At the end of the follow-up period <z:hpo ids='HP_0000001'>all</z:hpo> patients were free of HGIN / early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (one patient after surgery), and 23 patients (68 %) had complete endoscopic and histological eradication of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: SRER resulted in complete eradication of HGIN/early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in <z:hpo ids='HP_0000001'>all</z:hpo> patients, and eradication of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> in a majority of cases </plain></SENT>
<SENT sid="15" pm="."><plain>A significant number of patients develop <z:hpo ids='HP_0002015'>dysphagia</z:hpo>, which can be successfully treated endoscopically </plain></SENT>
</text></document>